At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
Extended release naltrexone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
In Brief
A clinical study evaluating Extended release naltrexone and Placebo for Methamphetamine Abuse and HIV. Completed, enrolled 76 participants across 2 sites.
Detailed Summary
The purpose of this protocol is to learn more about impulsive decision making in people who use methamphetamines. The investigators would like to know if a medication called naltrexone changes how people make decisions. The investigators would also like to know whether changes in decision making can be observed by MRI (magnetic resonance imaging). The research is conducted in Portland, OR.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMethamphetamine Abuse, HIV
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 2013
Enrollment StartMay 2013
Primary CompletionMar 2015
TodayJul 2026
First PostedApr 2, 2013
Enrollment StartMay 1, 2013
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.3 years ago
Interventions
Extended release naltrexonedrug
Placebodrug